Back to top
more

IPSEN (IPSEY)

(Delayed Data from OTC)

$29.89 USD

29.89
228

0.00 (0.00%)

Updated Jul 19, 2024 01:07 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (146 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for IPSEY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for IPSEN falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 583 1,265 1,028 790 462
Receivables 798 710 813 639 658
Notes Receivable NA 0 0 0 0
Inventories 313 299 260 244 240
Other Current Assets 360 252 211 130 148
Total Current Assets 2,055 2,526 2,312 1,803 1,508
Net Property & Equipment 622 613 766 739 761
Investments & Advances 143 144 158 145 125
Other Non-Current Assets NA 0 0 0 0
Deferred Charges 352 338 299 283 167
Intangibles 3,618 2,281 2,384 1,958 2,258
Deposits & Other Assets 55 6 5 4 5
Total Assets 6,843 5,908 5,924 4,932 4,824
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 10 4 7 3 16
Accounts Payable 835 682 704 566 570
Current Portion Long-Term Debt 135 120 207 467 683
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable 45 12 12 12 15
Other Current Liabilities 736 589 524 338 343
Total Current Liabilities 1,761 1,407 1,453 1,386 1,627
Mortgages NA 0 0 0 0
Deferred Taxes/Income 245 82 120 91 121
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 699 904 1,092 1,031 1,113
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 2,705 2,393 2,665 2,508 2,860
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) 91 88 99 96 94
Capital Surplus 3,356 2,684 2,347 1,767 1,855
Retained Earnings 697 683 765 626 -57
Other Equity -6 60 47 -65 71
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 4,139 3,516 3,258 2,424 1,963
Total Liabilities & Shareholder's Equity 6,843 5,908 5,924 4,932 4,824
Total Common Equity 104,138 3,516 3,258 2,424 1,963
Shares Outstanding NA NA 335.20 335.20 335.10
Book Value Per Share -1.04 -0.04 9.72 7.23 5.86

Fiscal Year End for IPSEN falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 -99,999 583 -99,999 478
Receivables NA NA 798 NA 748
Notes Receivable NA NA NA NA NA
Inventories NA NA 313 NA 382
Other Current Assets NA NA 360 NA 312
Total Current Assets NA NA 2,055 NA 1,919
Net Property & Equipment NA NA 622 NA 623
Investments & Advances NA NA 143 NA 122
Other Non-Current Assets NA NA NA NA NA
Deferred Charges NA NA 352 NA 379
Intangibles NA NA 3,618 NA 3,521
Deposits & Other Assets NA NA 55 NA 77
Total Assets NA NA 6,843 NA 6,641
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA 10 NA 1
Accounts Payable NA NA 835 NA 814
Current Portion Long-Term Debt NA NA 135 NA 373
Current Portion Capital Leases NA NA NA NA NA
Accrued Expenses NA NA NA NA NA
Income Taxes Payable NA NA 45 NA 27
Other Current Liabilities NA NA 736 NA 650
Total Current Liabilities NA NA 1,761 NA 1,864
Mortgages NA NA NA NA NA
Deferred Taxes/Income NA NA 245 NA 325
Convertible Debt NA NA NA NA NA
Long-Term Debt NA NA NA NA NA
Non-Current Capital Leases NA NA NA NA NA
Other Non-Current Liabilities NA 699 NA 741
Minority Interest (Liabilities) NA NA NA NA NA
Total Liabilities NA NA 2,705 NA 2,930
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA NA NA NA
Common Stock (Par) NA NA 91 NA 91
Capital Surplus NA NA 3,356 NA 3,373
Retained Earnings NA NA 697 NA 213
Other Equity NA NA -6 NA 34
Treasury Stock NA NA NA NA NA
Total Shareholder's Equity NA NA 4,139 NA 3,711
Total Liabilities & Shareholder's Equity NA NA 6,843 NA 6,641
Total Common Equity 0 0 104,138 0 103,710
Shares Outstanding NA NA NA NA NA
Book Value Per Share 0.00 0.00 -1.04 0.00 -1.04